SEO URLwww.firestrike.ai/deals/avadel-pharmaceuticals-alkermes-acquisition-2026-1
acquisitionAnnounced · Jan 12, 2026PharmaceuticalsSource · Unverified ReportsArticle · Factual
Alkermes acquires Avadel Pharmaceuticals
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
$2.1B
Target
Avadel Pharmaceuticals
NASDAQ: AVDL · Dublin, Leinster
Acquirer
Alkermes
Full Acquisition
Status
Pending
Alkermes agreed to acquire Avadel Pharmaceuticals. Reported deal value: $2.1B. Status: Pending. Sector: Pharmaceuticals. Target headquarters context: Dublin, Leinster, Ireland.
This page summarizes publicly available information about the transaction as of 2026-01-12. Figures and status may change as filings and press coverage update.
Avadel Pharmaceuticals shareholders back Alkermes acquisition
Deal timeline
Announced
Jan 12, 2026 · stocktitan.net
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Pharmaceuticals with a reported deal value of $2.1B. Figures and status may change as sources update.
Sources: stocktitan.net · Primary article · FireStrike proprietary index